Business Description
CombiGene AB
ISIN : SE0016101935
Compare
Compare
Traded in other countries / regions
COMBI.SwedenCOJ0.Germany IPO Date
2015-05-25Description
CombiGene AB is a gene therapy explorer based in Sweden. The company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present. It develops gene therapies with the ambition to offer patients affected by severe life-changing diseases opportunities for a better life.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.66 | |||||
| Beneish M-Score | -3.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.6 | |||||
| 3-Year EPS without NRI Growth Rate | 18.4 | |||||
| 3-Year FCF Growth Rate | 28.9 | |||||
| 3-Year Book Growth Rate | -0.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.34 | |||||
| 9-Day RSI | 33.14 | |||||
| 14-Day RSI | 36.22 | |||||
| 6-1 Month Momentum % | 40.77 | |||||
| 12-1 Month Momentum % | -45.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 24.84 | |||||
| Quick Ratio | 24.84 | |||||
| Cash Ratio | 24.37 | |||||
| Days Sales Outstanding | 119.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -696.28 | |||||
| Net Margin % | -643.33 | |||||
| FCF Margin % | -551.17 | |||||
| ROE % | -27.01 | |||||
| ROA % | -25.92 | |||||
| ROIC % | -165.55 | |||||
| ROC (Joel Greenblatt) % | -4190.72 | |||||
| ROCE % | -27.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.75 | |||||
| PB Ratio | 0.56 | |||||
| Price-to-Tangible-Book | 0.65 | |||||
| EV-to-EBIT | 1.01 | |||||
| EV-to-EBITDA | 1.1 | |||||
| EV-to-Revenue | -6.56 | |||||
| EV-to-FCF | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 0.66 | |||||
| Price-to-Net-Cash | 0.67 | |||||
| Earnings Yield (Greenblatt) % | 98.6 | |||||
| FCF Yield % | -47.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CombiGene AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 5.544 | ||
| EPS (TTM) (kr) | -1.8 | ||
| Beta | 0 | ||
| Volatility % | 65.14 | ||
| 14-Day RSI | 36.22 | ||
| 14-Day ATR (kr) | 0.203069 | ||
| 20-Day SMA (kr) | 3.6365 | ||
| 12-1 Month Momentum % | -45.47 | ||
| 52-Week Range (kr) | 2 - 7.86 | ||
| Shares Outstanding (Mil) | 19.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CombiGene AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CombiGene AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
CombiGene AB Frequently Asked Questions
What is CombiGene AB(OSTO:COMBI)'s stock price today?
The current price of OSTO:COMBI is kr3.28. The 52 week high of OSTO:COMBI is kr7.86 and 52 week low is kr2.00.
When is next earnings date of CombiGene AB(OSTO:COMBI)?
The next earnings date of CombiGene AB(OSTO:COMBI) is 2024-08-23.
Does CombiGene AB(OSTO:COMBI) pay dividends? If so, how much?
CombiGene AB(OSTO:COMBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers